Digestive Health and Surgery

Driving Digestive Care Forward

The AdventHealth Digestive Health and Surgery Institute is at the forefront of advanced care for complex diseases in Central Florida — and we’re raising the bar for the industry globally, too. From being home to the largest interventional endoscopy center in the U.S. to holding multiple accreditations for our subspecialty programs, we bring world-class care close to home. Our well-connected, multi-specialty care team has made our institute a destination for digestive and surgical care.

Recent News

HAI pump
News
Hepatic Arterial Infusion Pump Offers New Hope to Patients with Liver Metastases from Colorectal and Bile Duct Cancers

In June, AdventHealth Cancer Institute (AHCI) became the second center in Florida to offer hepatic artery infusion (HAI) as a treatment...

Mustafa Arain, M.D., is the medical director of the Pancreas Center at AdventHealth Center for Interventional Endoscopy.
News
AdventHealth opens first dedicated Pancreas Center in Central Florida
AdventHealth Center for Interventional Endoscopy (CIE) physicians in operating room
News
Recognizing 10 years of excellence and innovation at AdventHealth Center for Interventional Endoscopy
WFMZ-TV

AdventHealth Clinicians in the News

In every specialty, AdventHealth clinicians pioneer innovations that inspire healing and lead their fields in medical breakthroughs for the future of health care. Read how our world-class physicians are making headlines for an advanced robotic surgery system to remove colon polyps.

Highlighted Digestive Health and Surgery Trials

3 items. To interact with these items, press Control-Option-Shift-Right Arrow
  • Now Enrolling

    A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis.

    Principal Investigator:

    Muhammed Hasan, MD

  • Now Enrolling

    Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease.

    Principal Investigator:

    Muhammed Hasan, MD

  • Now Enrolling

    A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Subject with Moderately to Severely Active Crohn’s Disease.

    Principal Investigator:

    Muhammed Hasan, MD

Hexagon Background Image
Close up of Da Vinci Robotic Surgical System in operating room

Nationally Ranked Digestive Health and Surgery Experts

AdventHealth’s gastroenterology and hepatology program has an enormous breadth of clinical and research expertise for learners and faculty peers. Our clinical trial developmental program allows us to improve existing therapies and provide novel treatment for patients with ulcerative colitis, Crohn’s disease, esophageal and colorectal cancers, and more. Learn about our team’s latest research.